Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Acelrx Pharmaceutica (NQ: ACRX )

1.200 USD -0.080 (-6.25%)
Official Closing Price Updated: 7:03 PM EDT, Apr 16, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,920,754
Open 1.270
Bid (Size) 1.210 (10)
Ask (Size) 1.220 (44)
Prev. Close 1.280
Today's Range 1.200 - 1.270
52wk Range 1.010 - 2.940
Shares Outstanding 118,947,830
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
AcelRx Announces an Investigator-Initiated Study of DSUVIA® in Patients Taking Buprenorphine Who Require a Surgical Procedure
AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in healthcare institutions,... 
From PR Newswire
AcelRx Pharmaceuticals Announces Appointment of Marina Bozilenko to the Board of Directors
AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today... 
From PR Newswire

Performance

YTD
-4.00%
-4.00%
1 Month
-35.48%
-35.48%
3 Month
-35.48%
-35.48%
6 Month
-28.57%
-28.57%
1 Year
-6.98%
-6.98%

More News

Read More
AcelRx Pharmaceuticals Announces Clinical Data Reporting High Ratings for Healthcare Professional and Patient Satisfaction Following Use of DSUVIA® for Acute Pain in Hospital Settings
From PR Newswire
AcelRx Announces Presentation and Fireside Chat at the Benzinga Biotech Small Cap Conference
From PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AcelRx Pharmaceuticals, Inc. (ACRX)
From PR Newswire
AcelRx Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results
From PR Newswire
First Week of December 17th Options Trading For AcelRx Pharmaceuticals (ACRX)
Tags Stocks
From Market News Video
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AcelRx Pharmaceuticals, Inc. (ACRX)
From PR Newswire
12 Health Care Stocks Moving In Thursday's After-Market Session
Tags Market News KMPH AVIR
From Benzinga
AcelRx To Test Dsuvia In Patients On Buprenorphine Requiring A Surgical Procedure
Tags ACRX Health Care News
From Benzinga
ROCE Insights For AcelRx Pharmaceuticals
Tags Market News Benzinga Earnings
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.